Articles

Recherche fondamentale

• Portet S, Banor T, Bousquet J, Simonneau A, Flores M, Ingrand P, Milin S, Karayan-Tapon L, Bataille B. New Insights into Expression of Hormonal Receptors by Meningiomas. World Neurosurg. 2020 Aug;140:e87-e96. doi: 10.1016/j.wneu.2020.04.168 [↗]. Epub 2020 May 1. PMID: 32371078 [↗].
• Joussaume A, Karayan-Tapon L, Benzakour O, Dkhissi F. A Comparative Study of Anoikis Resistance Assays for Tumor Cells. Biomed J Sci & Tech Res 29(2)-2020. BJSTR. doi: 10.26717/BJSTR.2020.29.004767 [↗]. IF=ND
• Pelé T, Giraud S, Delwail A, Joffrion S, Benzakour O et al., Detection of Platelet-Derived Microparticles in Blood Samples by Flow Cytometry: The Importance of Choosing the Adequate Control. Biomed J Sci & Tech Res 29(2)-2020. BJSTR. DOI: 10.26717/BJSTR.2020.29.004775 [↗]. IF=ND
• Chepied A, Daoud-Omar Z, Meunier-Balandre A-C, Laird DW, Mesnil M, Defamie N. Involvement of the Gap Junction Protein, Connexin43, in the Formation and Function of Invadopodia in the Human U251 Glioblastoma Cell Line. Cells. 2020 Jan 3;9(1). pii: E117. doi: 10.3390/cells9010117 [↗]. PubMed PMID: 31947771 [↗]; PubMed Central PMCID: PMC7017254 [↗]. IF=5.656

Recherche clinique & translationnelle

• Tougeron D, Sueur B, Zaanan A, De La Fouchardiere C, Sefrioui D, Lecomte T, Aparicio T, Des Guetz G, Artru P, Hautefeuille V, Coriat R, Moulin V, Locher C, Touchefeu Y, Lecaille C, Goujon G, Ferru A, Evrard C, Chautard R, Gentilhomme L, Vernerey D, Taieb J, André T, Henriques J, Cohen R. Prognosis and Chemosensitivity of Deficient MMR Phenotype in Patients with Metastatic Colorectal Cancer: an AGEO Retrospective Multicenter Study. Int J Cancer. 2020 Jan 22. doi: 10.1002/ijc.32879 [↗]. PMID: 31970760 [↗]. IF=4.9
• Tougeron D, Emambux S, Favot L, Lecomte T, Wierzbicka-Hainaut E, Samimi M, Frouin E, Azzopardi N, Chevrier J, Serres L, Godet J, Levillain P, Paintaud G, Ferru A, Rouleau L, Delwail A, Silvain C, Tasu JP, Morel F, Ragot S, Lecron JC. Skin inflammatory response and efficacy of anti-epidermal growth factor receptor therapy in metastatic colorectal cancer (CUTACETUX). Oncoimmunology. 2020 Nov 29;9(1):1848058. doi: 10.1080/2162402X.2020.1848058 [↗]. PMID: 33299659 [↗]; PMCID: PMC7714491 [↗]. IF=5.869
• Richard S, Tachon G, Milin S, Wager M, Karayan-Tapon L. Dual MGMT inactivation by promoter hypermethylation and loss of the long arm of chromosome 10 in glioblastoma. Cancer Med. 2020 Sep;9(17):6344-6353. doi: 10.1002/cam4.3217 [↗]. Epub 2020 Jul 14. PMID: 32666673 [↗]; PMCID: PMC7476845 [↗]. IF=3.362
• Junca A, Tachon G, Evrard C, Villalva C, Frouin E, Karayan-Tapon L, Tougeron D. Detection of Colorectal Cancer and Advanced Adenoma by Liquid Biopsy (Decalib Study): The ddPCR Challenge. Cancers (Basel). 2020 Jun 6;12(6):1482. doi: 10.3390/cancers12061482 [↗]. PMID: 32517177 [↗]; PMCID: PMC7352444 [↗]. IF=6.126
• Zaanan A, Henriques J, Cohen R, Sefrioui D, Evrard C, de la Fouchardiere C, Lecomte T, Aparicio T, Svrcek M, Taieb J, André T, Vernerey D, Tougeron D; Association des Gastro-entérologues Oncologues (AGEO). Efficacy of anti-EGFR in MSI metastatic colorectal cancer depending on sporadic or familial origin. J Natl Cancer Inst. 2020 May 16:djaa072. doi: 10.1093/jnci/djaa072 [↗]. Epub ahead of print. PMID: 32415973 [↗]; PMCID: PMC8023852 [↗]. IF=12.589
• Randrian V, Biau J, Benoît C, Pezet D, Lapeyre M, Moreau J. Radiothérapie avec modulation d’intensité préopératoire des cancers rectaux : intérêt et application [Preoperative intensitymodulated radiotherapy of rectal cancers: Relevance and modalities]. Cancer Radiother. 2020 Jul;24(4):345-353. French. doi: 10.1016/j.canrad.2019.11.005 [↗]. Epub 2020 Apr 28. PMID: 32360094 [↗]. IF=1.014
• Randrian V, Adenis A, Desrame J, Barbier E, Di Fiore F, Lièvre A, Dahan L, Laurent-Puig P, Mineur L, Breysacher G, Roquin G, Louafi S, Lopez A, Louvet C, Borg C, Metges JP, Faroux R, Gaba L, Manfredi S, Tougeron D. Nal-IRI/LV5-FU versus paclitaxel as second-line therapy in patients with metastatic esophageal squamous cell carcinoma (OESIRI)-PRODIGE 62: A multicentre, randomised, noncomparative phase II study. Dig Liver Dis. 2020 Mar;52(3):347-350. doi: 10.1016/j.dld.2019.11.014 [↗]. Epub 2019 Dec 30. PubMed PMID: 31899122 [↗]. IF=3.037
• Tougeron D, Sueur B, Zaanan A, de la Fouchardiére C, Sefrioui D, Lecomte T, Aparicio T, Des Guetz G, Artru P, Hautefeuille V, Coriat R, Moulin V, Locher C, Touchefeu Y, Lecaille C, Goujon G, Ferru A, Evrard C, Chautard R, Gentilhomme L, Vernerey D, Taieb J, André T, Henriques J, Cohen R; Association des Gastro-entérologues Oncologues (AGEO). Prognosis and chemosensitivity of deficient MMR phenotype in patients with metastatic colorectal cancer: An AGEO retrospective multicenter study. Int J Cancer. 2020 Jul 1;147(1):285-296. doi: 10.1002/ijc.32879 [↗]. Epub 2020 Feb 13. PMID: 31970760 [↗]. IF=5.145
• Patrikidou A, Chaigneau L, Isambert N, Kitikidou K, Shanley R, Ray-Coquard I, Valentin T, Malivoir B, Laigre M, Bay JO, Moureau-Zabotto L, Bompas E, Piperno-Neumann S, Penel N, Alcindor T, Guillemet C, Duffaud F, Hügli A, Le Pechoux C, Dhermain F, Blay JY, Sperduto PW, Le Cesne A. Development of a disease-specific graded prognostic assessment index for the management of sarcoma patients with brain metastases (Sarcoma-GPA). BMC Cancer. 2020 Feb 12 ; 20(1):117. doi : 10.1186/s12885-020-6548-6 [↗]. PMID : 32050939 [↗] ; PMCID : PMC7014599 [↗].
  

Revues scientifiques

• Cohen R, Pudlarz T, Garcia-Larnicol ML, Vernerey D, Dray X, Clavel L, Jary M, Piessen G, Zaanan A, Aparicio T, Louvet C, Tournigand C, Chibaudel B, Tougeron D, Guimbaud R, Benouna J, Adenis A, Sokol H, Borg C, Duval A, Svrcek M, André T. [Localized MSI/dMMR gastric cancer patients, perioperative immunotherapy instead of chemotherapy: The GERCOR NEONIPIGA phase II study is opened to recruitment]. Bull Cancer. 2020 Apr;107(4):438-446. pii: S0007-4551(20)30037-0. doi: 10.1016/j.bulcan.2019.11.016 [↗]. Epub 2020 Feb 10. Review. French. PMID: 32057467 [↗]. HAL id: hal-02995557 [↗]. IF=0.729

Chapitres

• Evrard C, Tachon G, Tougeron D. Carcinogenèse colorectale, données fondamentales. EM Consulte Gastro-entérologie. 2020. doi: 10.1016/S1155-1968(20)41952-2 [↗].
• Tougeron D. Chapitre 11 : Immunothérapie des adénocarcinomes gastriques, dans Adénocarcinome de l’estomac ; Rapport de l’AFC 2020 [↗]. pp: 123-142. Éditions: John Libbey Eurotext; Éditeurs: Gronnier C, Pezet D.